To further investigate whether the expression of S100A8 and S100A9 in tumor cells was associated with disease progression, we analyzed their expression against the clinicopathological parameters, including gender, age, tumor location, tumor size, histological differentiation, Dukes stage and lymph node metastasis (Table 3). The gene discussed is S100A8; the disease is neoplasm.